Editor's Note: Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-KB ligand and by tumor cells by suppressing nuclear factor-KB activation

Clinical Cancer Research Editors

Research output: Contribution to journalComment/debatepeer-review

Abstract

The Clinical Cancer Research editors are publishing this note to alert readers to a concern about this article (1). Institutional review determined that the same image was used to represent inhibition of RANKL-induced osteoclastogenesis by p65 and PTD in Fig. 5A. The authors were unable to provide original data for these images at the time of institutional review.

Original languageEnglish (US)
Pages (from-to)4347
Number of pages1
JournalClinical Cancer Research
Volume24
Issue number17
DOIs
StatePublished - Sep 1 2018
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Editor's Note: Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-KB ligand and by tumor cells by suppressing nuclear factor-KB activation'. Together they form a unique fingerprint.

Cite this